Cogent Biosciences shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Cogent Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cogent Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cogent Biosciences by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.1M | 75k | 14.36 |
| 2025-03-31 | $450k | 75k | 5.99 |
| 2024-12-31 | $479k | 62k | 7.80 |
| 2024-09-30 | $700k | 65k | 10.80 |
| 2024-06-30 | $498k | 59k | 8.43 |
| 2024-03-31 | $582k | 87k | 6.72 |
| 2023-12-31 | $724k | 123k | 5.88 |
| 2023-09-30 | $2.6M | 269k | 9.75 |
| 2023-06-30 | $3.2M | 267k | 11.84 |
| 2023-03-31 | $2.0M | 186k | 10.55 |
| 2022-12-31 | $2.8M | 241k | 11.42 |
| 2022-06-30 | $3.1M | 356k | 8.77 |
| 2022-03-31 | $1.2M | 164k | 7.48 |
| 2021-12-31 | $1.8M | 216k | 8.29 |
| 2021-03-31 | $2.2M | 248k | 8.81 |
| 2020-12-31 | $776k | 67k | 11.54 |